EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Concomitant Radiotherapy and Chemotherapy for High-Risk Nonmelanoma Skin Carcinomas of the Head and Neck

Smith Apisarnthanarax, Nirav Dhruva, Farhad Ardeshirpour, Joel E Tepper, Carol G Shores, Julian G Rosenman, William W Shockley, Michele C Hayward, D Neil Hayes

International Journal of Surgical Oncology · 2011

DOI: 10.1155/2011/464829 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Surgical Oncology, 2011. Verfasst von Smith Apisarnthanarax und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA 19104, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To report on the use and feasibility of a multimodality approach using concomitant radiotherapy and chemotherapy in patients with high-risk nonmelanoma skin carcinoma (NMSC) of the head and neck.

Methods

Records of patients with NMSC of the head and neck who received concomitant CRT at the University of North Carolina between 2001 and 2007 were reviewed.

Results

Fifteen identified patients had at least one of the following high-risk factors: T4 disease (93%), unresectability (60%), regional nodal involvement (40%), and/or recurrence (47%). Ten patients were treated in the definitive setting and five in the postoperative setting. Platinum based chemotherapy was given in 14 (93%) patients. Ten of fifteen (67%) patients completed all planned chemotherapy treatments, and thirteen patients (87%) completed at least 80% of planned chemotherapy. Mild radiation dermatitis occurred in all patients and reached grade 3 in 13% of patients. No patients experienced grade 4 or 5 toxicity. With a median followup of 31 months in surviving patients, the 2-year actuarial locoregional control and relapse-free survival were 79% and 49%, respectively.

Conclusions

Definitive or postoperative chemoradiotherapy for patients with locally advanced or regionally metastasized NMSC of the head and neck appears feasible with acceptable toxicities and favorable locoregional control.

Autor:innen und Institutionen

  • Department of Radiation Oncology, University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA 19104, USA.

Zitieren

APA

Apisarnthanarax, S., Dhruva, N., Ardeshirpour, F., Tepper, J. E., Shores, C. G., Rosenman, J. G., Shockley, W. W., Hayward, M. C., & Hayes, D. N. (2011). Concomitant Radiotherapy and Chemotherapy for High-Risk Nonmelanoma Skin Carcinomas of the Head and Neck. International Journal of Surgical Oncology. https://doi.org/10.1155/2011/464829

Vancouver

Apisarnthanarax S, Dhruva N, Ardeshirpour F, Tepper JE, Shores CG, Rosenman JG, et al. Concomitant Radiotherapy and Chemotherapy for High-Risk Nonmelanoma Skin Carcinomas of the Head and Neck. International Journal of Surgical Oncology. 2011. doi:10.1155/2011/464829

BibTeX
@article{Apisarnthanarax2011,
  author = {Apisarnthanarax, Smith and Dhruva, Nirav and Ardeshirpour, Farhad and Tepper, Joel E and Shores, Carol G and Rosenman, Julian G and Shockley, William W and Hayward, Michele C and Hayes, D Neil},
  title = {Concomitant Radiotherapy and Chemotherapy for High-Risk Nonmelanoma Skin Carcinomas of the Head and Neck},
  journal = {International Journal of Surgical Oncology},
  year = {2011},
  doi = {10.1155/2011/464829}
}
Kostenlos starten →